Form 4: KORU Medical Systems Director Robert Cascella Reports Acquisition of Shares
SEC Form 4 Filing
Director Robert Cascella acquired 6,329 shares of KORU Medical Systems at $2.37 per share on March 31, 2024.
Summary
- On March 31, 2024, Robert Cascella, a director of KORU Medical Systems, acquired 6,329 shares of common stock.
- The shares were purchased at a price of $2.37 per share.
- Following the transaction, Cascella's direct ownership in KORU Medical Systems is 59,620 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a small transaction.
Positives
- A director's purchase of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of transaction: Robert Cascella acquired shares of KORU Medical Systems. |
| 04/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.